Answer
During Co-amilofruse treatment, regular monitoring of serum sodium, potassium, creatinine and glucose is generally recommended, with particularly close monitoring in patients at high risk of electrolyte imbalances or with significant additional fluid loss.
Sources for this answer
- Co-Amilofruse 5/40mg TabletsAurobindo Pharma - Milpharm Ltd. · emc · SmPC §4.4 Special warnings and precautions for use · Version 13Document updated
Sources checked